KNTK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kinetik Holdings Inc. (KNTK) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, and increasing hedge fund interest. Despite neutral technical indicators, the stock's long-term prospects are supported by higher commodity prices, upcoming projects, and dividend stability.
The technical indicators are mixed. The MACD is negative (-0.132) but contracting, RSI is neutral at 58.23, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 48.259), with key support at 45.123. Overall, no strong short-term signals are present, but the bullish moving averages suggest longer-term strength.
Hedge funds are aggressively buying, with a 3936.59% increase in buying activity last quarter.
Analysts have raised price targets recently, with multiple firms projecting $50 or higher.
Strong Q4 2025 financial performance, including a 44149.37% YoY increase in net income and a 21700.00% YoY increase in EPS.
Dividend stability with a declared cash dividend of $0.81 per share and a Dividend Reinvestment Plan (DRIP).
Waha price-related curtailments remain a headwind, though partially offset by marketing benefits.
Options data shows a bearish sentiment with a high Option Volume Put-Call Ratio of 2.67.
Kinetik Holdings reported strong Q4 2025 financials with an 11.59% YoY revenue increase to $430.4 million, a 44149.37% YoY net income increase to $139.8 million, and a 21700.00% YoY EPS increase to $2.18. Gross margin also improved to 35.02%, up 16.81% YoY.
Analysts are generally positive on KNTK. RBC, Jefferies, and Scotiabank have raised price targets to $50 or higher, with RBC and Scotiabank maintaining Outperform ratings. Wells Fargo upgraded the stock to Overweight, citing structural shifts in energy markets. Truist initiated coverage with a Buy rating and a $53 price target. UBS is neutral with a $48 target, while Barclays remains cautious with an Equal Weight rating but raised its target to $46.
